CLINICAL_TRIALS
trial_result
· 2018-03-29
Clinical Trial Update: Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes [Phase 3]
Summary
Phase 3 clinical trial evaluating dapagliflozin for inadequately controlled type 1 diabetes has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2018-03-29